Moderate-intensity statin plus ezetimibe combination therapy versus high-intensity statin monotherapy according to baseline LDL-C levels: a prespecified subgroup analysis of RACING Trial

被引：0
|
作者：
Lee, B. [1 ]
Hong, S. [1 ]
Kim, J. [1 ,7 ]
Rha, S. [2 ]
Heo, J. [3 ]
Hur, S. [4 ]
Choi, H. [5 ]
Kim, K. [6 ]
Kim, J. [1 ,7 ]
Kim, H. [8 ]
Kim, W. [9 ]
Choi, Y. [10 ]
Kim, B. [1 ]
Hong, M. [1 ]
Jang, Y. [11 ]
机构：
[1] Yonsei Univ, Seoul, South Korea
[2] Korea Univ, Guro Hosp, Seoul, South Korea
[3] Kosin Univ, Sch Med, Busan, South Korea
[4] Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea
[5] Hallym Univ, Chunchon, South Korea
[6] Ewha Womans Univ, Seoul, South Korea
[7] Chonnam Natl Univ Hosp, Gwangju, South Korea
[8] Chosun Univ Hosp, Gwangju, South Korea
[9] Yeungnam Univ Hosp, Daegu, South Korea
[10] Eulji Univ Hosp, Deajeon, South Korea
[11] Cha Bundang, Med Ctr, Seongnam, South Korea
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 47 条
  • [1] Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial
    Lee, Bom
    Hong, Sung-Jin
    Rha, Seung-Woon
    Heo, Jung Ho
    Hur, Seung-Ho
    Choi, Hyun Hee
    Kim, Kyung-Jin
    Kim, Ju Han
    Kim, Hyun Kuk
    Kim, Ung
    Choi, Yu Jeong
    Lee, Yong-Joon
    Lee, Seung-Jun
    Ahn, Chul-Min
    Ko, Young-Guk
    Kim, Byeong-Keuk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Kim, Jung-Sun
    [J]. ATHEROSCLEROSIS, 2023, 386
  • [2] High-intensity statin monotherapy versus moderate-intensity statin plus ezetimibe therapy: Effects on vascular biomarkers
    Ferreira, C. E. S.
    Franca, C. N.
    Izar, M. C. O.
    Camargo, L. M.
    Roman, R. M.
    Fonseca, F. A. H.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 180 : 78 - 79
  • [3] Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial
    Lee, Yong-Joon
    Lee, Sang-Hyup
    You, Seng Chan
    Lee, Yong-ho
    Lee, Seung-Jun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Kim, Jung-Sun
    [J]. DIABETES OBESITY & METABOLISM, 2024, 26 (03): : 829 - 839
  • [4] Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
    Byung Gyu Kim
    Seung-Jun Lee
    Yong-Joon Lee
    Seng Chan You
    Soon Jun Hong
    Kyeong Ho Yun
    Bum-Kee Hong
    Jung Ho Heo
    Seung-Woon Rha
    Sung-Jin Hong
    Chul-Min Ahn
    Byeong-Keuk Kim
    Young-Guk Ko
    Donghoon Choi
    Myeong-Ki Hong
    Yangsoo Jang
    Yun-Hyeong Cho
    Jung-Sun Kim
    [J]. Scientific Reports, 13
  • [5] Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis
    Kim, Byung Gyu
    Lee, Seung-Jun
    Lee, Yong-Joon
    You, Seng Chan
    Hong, Soon Jun
    Yun, Kyeong Ho
    Hong, Bum-Kee
    Heo, Jung Ho
    Rha, Seung-Woon
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Cho, Yun-Hyeong
    Kim, Jung-Sun
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial
    Lee, Yong-Joon
    Cho, Jae Young
    You, Seng Chan
    Lee, Yong-Ho
    Yun, Kyeong Ho
    Cho, Yun-Hyeong
    Shin, Won-Yong
    Im, Sang Wook
    Kang, Woong Chol
    Park, Yongwhi
    Lee, Sung Yoon
    Lee, Seung-Jun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Kim, Jung-Sun
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (11) : 972 - +
  • [7] In ASCVD, moderate-intensity statin plus ezetimibe was noninferior to high-intensity statin alone at 3 y
    Kelsey, Michelle D.
    Newby, L. Kristin
    [J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (11) : JC126 - JC126
  • [8] Comparative Effectiveness of Moderate-Intensity Statin With Ezetimibe Combination Therapy Versus High-Intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study
    Jang, Ji-Yong
    Kim, Seonji
    Cho, Jaehyeong
    You, Seng Chan
    Kim, Jung-Sun
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B62 - B62
  • [9] Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease A Post Hoc Analysis From the RACING Randomized Clinical Trial
    Lee, Seung-Jun
    Cha, Jung-Joon
    Choi, Woong Gil
    Lee, Wang-Soo
    Jeong, Jin-Ok
    Choi, Seonghoon
    Cho, Yoon-Haeng
    Park, Woojung
    Yoon, Chang-Hwan
    Lee, Yong-Joon
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    Hong, Soon Jun
    Kim, Jung-Sun
    [J]. JAMA CARDIOLOGY, 2023, 8 (09) : 853 - 858
  • [10] Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies
    Ah, Young-Mi
    Jeong, Minseob
    Choi, Hye Duck
    [J]. PLOS ONE, 2022, 17 (03):
12345